SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Galirayo who wrote (999)6/8/2005 2:34:46 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
SCLN Is going over its June 3 H. It is up 22% with volume now up to 1,3351,753 which is still below the volume on June 2.<g>

The stock traded above the $4 level (4.11 at 1.39PM) but has faded some since then. Will see if it can close above its Feb.2 H of 3.82 <g>

bigcharts.marketwatch.com

SCLN reportedly has more than $1 in Cash/Share and its Debt/Equit. is around 0.11

Although the revenues in the last 2Qs have been better and the loss also has been less, the EL for 2005 is essentially unchanged and for 2006 is more than double (around $0.65/shr.)

Bernard



To: Galirayo who wrote (999)6/8/2005 4:30:03 PM
From: tuck  Read Replies (1) | Respond to of 3722
 
I'm trying to find an entry in CIPH over the next few days. It recently ran away from my target entry of $1.70. They are expected to announce a partnership deal for their protein chip based ovarian cancer test by the end of the quarter. This should move the stock back over $3. It's anticipatory run seems to have broken down for the moment, going under the 10 day ema but finding support at the 50 day. You or anybody got a suggested target for entering by Friday?

TIA & Cheers, Tuck